Biotechnology

IVF Life the first clinic group in Europe to use Artificial Intelligence to non-invasively assess the genetic integrity of embryos

ADELAIDE, Australia, May 25, 2021 /PRNewswire/ -- IVF Life Group, a leading group of IVF clinics acrossSpain, UK, and Germany, will be among the first in Europe to use Artificial Intelligence (AI) to non-invasively assess embryos to determine their genetic integrity. The AI product Life Whisperer...

2021-05-25 17:15 2093

Renowned international investor Jim Rogers joins Life3 Biotech's Board of Investors

SINGAPORE, May 25, 2021 /PRNewswire/ -- Renowned international investor Jim Rogers has joined Singapore-based food tech company, Life3 Biotech (Life3) as a member of its Board of Investors.

2021-05-25 16:30 2830

Seegene reports solid results in the first quarter of 2021 with KRW 351.8 billion

* SEEGENE POSTS KRW 193.9 BIL. IN OPERATING PROFIT, UP 388% ON-YEAR * OPERATING PROFIT RATIO AT 55%, DESPITE CONSTANT INVESTMENT IN R&D AND EMPLOYEES SEOUL, South Korea, May 25, 2021 /PRNewswire/ -- Seegene Inc. (KQ 096530), a molecular diagnostics company reported its financial results for th...

2021-05-25 15:33 12289

Clinical Trial Application of ASC40 Combined with Bevacizumab to Treat Patients with Recurrent Glioblastoma Accepted by China NMPA

HANGZHOU and SHAOXING, China, May 25, 2021 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX code: 1672) today announces that following the consultation with China National Medical Products Administration (NMPA), the clinical trial application of ASC40 combined with bevacizumab to treat patients with re...

2021-05-25 08:30 3736

Antengene Appoints Kathryn Gregory as Vice President and Head of Corporate Business Development

SHANGHAI and HARTFORD, Conn., May 25, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology and...

2021-05-25 08:00 4806

SIRONA - The world's first and largest RCT comparing Sirolimus V/S Paclitaxel balloon for the treatment of Peripheral Arterial Disease progresses rapidly

JENA, Germany, May 25, 2021 /PRNewswire/ -- Concept Medical Inc., focused on vascular intervention drug delivery devices, releases status updates ofSIRONA Randomized Control Trial (RCT) which compares head-to-head,SIROlimus versus Paclitaxel Drug-Eluting BallooN...

2021-05-25 07:03 4246

Lifebit Awarded A Four-Year Contract for Hong Kong's Genome Project

Lifebit's precision medicine software will power Hong Kong's development of genomic medicine by supporting the Hong Kong Genome Institute to implement the first large-scale genome sequencing initiative, the Hong Kong Genome Project. The Project will empower medical professionals and researchers t...

2021-05-25 06:00 4195

TruDiagnostic signs an exclusive license agreement with Duke University to use the DunedinPoAm rate of aging algorithm.

LEXINGTON, Ky. and DURHAM, N.C., May 24, 2021 /PRNewswire/ -- Today, TruDiagnostic signs an exclusive license agreement to the DunedinPoAm pace of aging methylation prediction algorithm. Pace of Aging is how quickly a person's epigenetic markers are changing to hasten or slow their progression of...

2021-05-24 20:30 1751

Singapore-based HeMo Bioengineering Receives China's NMPA Approval for flagship Afentta(TM) Aspiration Catheter

SINGAPORE, May 24, 2021 /PRNewswire/ -- HeMo Bioengineering Ltd ("HeMo"), a Singapore-based medical device company with a focus on treating stroke patients, is pleased to announce that its Afentta™ intracranial thrombectomy aspiration catheter – a product developed byHeMo's branch in China – has ...

2021-05-24 20:01 2343

Seegene introduces an exclusive diagnostic system for diagnosing COVID-19 variants at ECCMID

SEOUL, Korea, May 24, 2021 /PRNewswire/ -- Seegene Inc. (KQ 096530), a biotechnology firm specializing in molecular diagnostics has once again been recognized for its unique system for diagnosing COVID-19 variants at this year's European Congress of Clinical Microbiology, the ECCMID. Seegene's...

2021-05-24 09:58 2205

A 'Game Changer' COVID-19 drug from Korea was introduced in a world class academic journal

SEOUL South Korea, May 23, 2021 /PRNewswire/ -- Hyundai Bioscience (KOSDAQ 048410) announced on the 24th that CNPharm, its major shareholding bio tech company, published an article containing the research results of CP-COV03, a Niclosamide-based oral treatment for COVID-19 based on its proprietar...

2021-05-24 08:16 2788

Novavax Announces Memorandum of Understanding to Explore Expansion of COVID-19 Vaccine Activities in South Korea

Novavax and SK bioscience reaffirm partnership during meeting with South Korean leaders GAITHERSBURG, Md., May 23, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced the signing of a non-...

2021-05-23 00:39 10015

Moderna and Samsung Biologics Announce Agreement for Fill-Finish Manufacturing of Moderna's COVID-19 Vaccine

CAMBRIDGE, Mass. and INCHEON, South Korea, May 22, 2021 /PRNewswire/ -- Moderna (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Samsung Biologics (KRX: 207940.KS), a leading global CDMO providing a fully integrated end-to-end contract develop...

2021-05-23 00:00 9843

Recently Merged dMed and Clinipace Announce the Appointment of New Global COO

SHANGHAI and MORRISVILLE, N.C., May 21, 2021 /PRNewswire/ -- Following the recent merger announcement ofShanghai-based dMed Global and NC-based Clinipace Incorporated, the combined company today announced the appointment ofSimon Britton to the position of Chief Operating Officer (COO).  Britton w...

2021-05-21 20:00 6246

Johnson & Johnson Medical Korea Ltd. and Johnson & Johnson Innovation LLC Announce Launch of Seoul Innovation QuickFire Challenge on Smart Surgery in Collaboration with Seoul Metropolitan Government and Korea Health Industry Development Institute

- QuickFire Challenge calls on innovators to submit novel ideas with the potential to transform the surgical pathway for optimized care, cost savings, and improved patient outcomes. - Awardee(s) will receive grant funding from a total of up to KRW150,000,0001 , one year of residency at the Seoul ...

2021-05-21 05:00 3763

BioVaxys Announces Appointment of Policy Advisor

VANCOUVER, BC, May 20, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA:5LB) (OTC:BVAXF)("BioVaxys"), a biotechnology company that is advancing viral and oncology vaccine platforms as well as immuno-diagnostic products, today announced the appointment ofAdam Coutts, PhD, as Policy ...

2021-05-20 20:00 12564

Everest Medicines Announces China NMPA Has Granted Priority Review for Sacituzumab Govitecan-hziy in Metastatic Triple-Negative Breast Cancer

SHANGHAI, May 20, 2021 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products inGreater China and other parts of Asia, announced today that sacit...

2021-05-20 19:04 6138

European Wellness and Dongci Join Forces To Bring Regenerative Medicine To Shandong, China

KOTA KINABALU, Malaysia, May 20, 2021 /PRNewswire/ -- European Wellness Biomedical Group has signed a memorandum of understanding (MOU) with Yantai Dongci ZhenAn Hospital Group to develop an exclusive multimillion dollar-project Regenerative Medicine Center inShandong, China. In a digital signin...

2021-05-20 16:54 3440

Kintor Announced (1) FDA Has Greenlighted Proxalutamide's Phase III Study for Hospitalized Male and Female COVID-19 Patients to Be Conducted; and (2) Inclusion of Female Outpatients in Proxalutamide's Phase III Study for Mild to Moderate COVID-19

SUZHOU, China, May 19, 2021 /PRNewswire/ -- On May 18, Kintor Pharmaceutical Limited (HKEX.9939), a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, announced that the U.S. Food and Drug Administration (FDA) has greenlighted proxalutamide's ph...

2021-05-20 09:47 9547

Alphamab Oncology to Present Multiple Clinical Research Data at the 2021 American Society of Clinical Oncology Annual Meeting (ASCO 2021)

SUZHOU, China, May 20, 2021 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced, data from three clinical studies of the PD-L1/CTLA-4 bispecific antibody KN046 will be presented in Poster session at the 2021 American Society of Clinical Oncology Annual Meeting (ASCO 2021) to be held...

2021-05-20 09:34 9228
1 ... 338339340341342343344 ... 347

Week's Top Stories